{
  "cik": 818033,
  "cik_padded": "0000818033",
  "entityName": "HERON THERAPEUTICS, INC. /DE/",
  "fiscal_years": [
    {
      "accn": "0001193125-26-073515",
      "filed": "2026-02-26",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 317000.0,
        "cash": 28647000.0,
        "cost_of_revenue": 41347000.0,
        "eps_diluted": -0.12,
        "free_cash_flow": -27908000.0,
        "gross_profit": 113557000.0,
        "net_income": -20195000.0,
        "operating_cash_flow": -27591000.0,
        "operating_income": -2538000.0,
        "revenue": 154904000.0,
        "stockholders_equity": 14333000.0,
        "total_assets": 255877000.0,
        "total_liabilities": 241544000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "gross_margin": 0.7330798429995352,
        "leverage": 16.852298890671875,
        "net_margin": -0.13037106853276867,
        "operating_margin": -0.01638434126943139,
        "revenue_growth_yoy": 0.07359739404650519,
        "roa_avg2y": -0.08259308336605156,
        "roa_period_end": -0.0789246395729198,
        "roe_avg2y": 2.0907961486696345,
        "roe_period_end": -1.4089862554943138
      }
    },
    {
      "accn": "0001193125-26-073515",
      "filed": "2026-02-26",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1706000.0,
        "cash": 25802000.0,
        "cost_of_revenue": 38648000.0,
        "eps_diluted": -0.09,
        "free_cash_flow": -24235000.0,
        "gross_profit": 105637000.0,
        "net_income": -13580000.0,
        "operating_cash_flow": -22529000.0,
        "operating_income": -11528000.0,
        "revenue": 144285000.0,
        "stockholders_equity": -33651000.0,
        "total_assets": 233147000.0,
        "total_liabilities": 266798000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "gross_margin": 0.7321412482240011,
        "net_margin": -0.094119277818207,
        "operating_margin": -0.07989742523477839,
        "revenue_growth_yoy": 0.13570888825918578,
        "roa_avg2y": -0.05960676216331287,
        "roa_period_end": -0.0582465140018958,
        "roe_avg2y": 0.4016325564888205
      }
    },
    {
      "accn": "0001193125-26-073515",
      "filed": "2026-02-26",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1545000.0,
        "cash": 28677000.0,
        "cost_of_revenue": 65105000.0,
        "eps_diluted": -0.8,
        "free_cash_flow": -60334000.0,
        "gross_profit": 61939000.0,
        "net_income": -110559000.0,
        "operating_cash_flow": -58789000.0,
        "operating_income": -110615000.0,
        "revenue": 127044000.0,
        "stockholders_equity": -33973000.0,
        "total_assets": 222506000.0,
        "total_liabilities": 256479000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "gross_margin": 0.4875397500078713,
        "net_margin": -0.8702418059884764,
        "operating_margin": -0.87068259815497,
        "revenue_growth_yoy": 0.17991678430789806,
        "roa_avg2y": -0.4670286847591228,
        "roa_period_end": -0.4968809829847285,
        "roe_avg2y": 10.838586343806677
      }
    },
    {
      "accn": "0001193125-26-073515",
      "filed": "2026-02-26",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 1825000.0,
        "cash": 15364000.0,
        "cost_of_revenue": 54874000.0,
        "eps_diluted": -1.67,
        "free_cash_flow": -148737000.0,
        "gross_profit": 52798000.0,
        "net_income": -182024000.0,
        "operating_cash_flow": -146912000.0,
        "operating_income": -174658000.0,
        "revenue": 107672000.0,
        "stockholders_equity": 13572000.0,
        "total_assets": 250951000.0,
        "total_liabilities": 237379000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "gross_margin": 0.4903596106694405,
        "leverage": 17.490347774830532,
        "revenue_growth_yoy": 0.24698306812127951,
        "roa_avg2y": -0.6539897998228712,
        "roa_period_end": -0.7253368187415073,
        "roe_avg2y": -3.994294617190757
      }
    },
    {
      "accn": "0000950170-25-028374",
      "filed": "2025-02-27",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 3022000.0,
        "cash": 90541000.0,
        "eps_diluted": -2.24,
        "free_cash_flow": -206376000.0,
        "net_income": -220683000.0,
        "operating_cash_flow": -203354000.0,
        "operating_income": -217828000.0,
        "revenue": 86346000.0,
        "stockholders_equity": 77570000.0,
        "total_assets": 305706000.0,
        "total_liabilities": 228136000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 2.9410339048601264,
        "revenue_growth_yoy": -0.025857984160292426,
        "roa_avg2y": -0.6694849695568681,
        "roa_period_end": -0.7218798453416028,
        "roe_avg2y": -1.4053467149798446,
        "roe_period_end": -2.844952945726441
      }
    },
    {
      "accn": "0001564590-22-007618",
      "filed": "2023-03-29",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 6813000.0,
        "cash": 105138000.0,
        "free_cash_flow": -191633000.0,
        "net_income": -227278000.0,
        "operating_cash_flow": -184820000.0,
        "operating_income": -228163000.0,
        "revenue": 88638000.0,
        "stockholders_equity": 236492000.0,
        "total_assets": 353556000.0,
        "total_liabilities": 117064000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.4950019450975086,
        "revenue_growth_yoy": -0.3927573166721473,
        "roa_avg2y": -0.5246866696370239,
        "roa_period_end": -0.6428345156071457,
        "roe_avg2y": -0.7098810451534919,
        "roe_period_end": -0.9610388512084975
      }
    },
    {
      "accn": "0001564590-22-007618",
      "filed": "2022-02-28",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 7154000.0,
        "cash": 71898000.0,
        "free_cash_flow": -131734000.0,
        "net_income": -204749000.0,
        "operating_cash_flow": -124580000.0,
        "operating_income": -210694000.0,
        "revenue": 145968000.0,
        "stockholders_equity": 403835000.0,
        "total_assets": 512782000.0,
        "total_liabilities": 108947000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.26978097490311637,
        "net_margin": -1.4026978515839088,
        "operating_margin": -1.4434259563739997,
        "revenue_growth_yoy": 0.884090146371686,
        "roa_avg2y": -0.42001474930792104,
        "roa_period_end": -0.39929053671930764,
        "roe_avg2y": -0.5290706012312741,
        "roe_period_end": -0.507011526985031
      }
    },
    {
      "accn": "0001564590-22-007618",
      "filed": "2022-02-28",
      "fiscal_year": 2018,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 9171000.0,
        "cash": 31836000.0,
        "free_cash_flow": -200976000.0,
        "net_income": -178840000.0,
        "operating_cash_flow": -191805000.0,
        "operating_income": -183937000.0,
        "revenue": 77474000.0,
        "stockholders_equity": 370160000.0,
        "total_assets": 462179000.0,
        "total_liabilities": 92019000.0
      },
      "period_end": "2018-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.2485925005403069,
        "revenue_growth_yoy": 1.5180875613481977,
        "roa_avg2y": -0.5135494467943361,
        "roa_period_end": -0.3869496450509435,
        "roe_avg2y": -0.7135105805751493,
        "roe_period_end": -0.4831424248973417
      }
    },
    {
      "accn": "0001564590-21-007841",
      "filed": "2021-02-24",
      "fiscal_year": 2017,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 2553000.0,
        "cash": 144583000.0,
        "free_cash_flow": -172853000.0,
        "net_income": -197484000.0,
        "operating_cash_flow": -170300000.0,
        "operating_income": -194558000.0,
        "revenue": 30767000.0,
        "stockholders_equity": 131136000.0,
        "total_assets": 234307000.0,
        "total_liabilities": 103171000.0
      },
      "period_end": "2017-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.7867481088335774,
        "revenue_growth_yoy": 23.055512118842845,
        "roa_avg2y": -1.3087554549701943,
        "roa_period_end": -0.8428429368307391,
        "roe_avg2y": -3.5943759384811393,
        "roe_period_end": -1.5059480234260616
      }
    },
    {
      "accn": "0001564590-20-007973",
      "filed": "2020-03-02",
      "fiscal_year": 2016,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 3135000.0,
        "cash": 13414000.0,
        "free_cash_flow": -137232000.0,
        "net_income": -173143000.0,
        "operating_cash_flow": -134097000.0,
        "operating_income": -170915000.0,
        "revenue": 1279000.0,
        "stockholders_equity": -21251000.0,
        "total_assets": 67482000.0,
        "total_liabilities": 88733000.0
      },
      "period_end": "2016-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-073515",
    "filed": "2026-02-26",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000818033.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0000818033.json"
  },
  "ticker": "HRTX"
}